6.1 Adequate pain relief as reported by the woman |
4 |
394 |
Risk Ratio (M‐H, Fixed, 95% CI) |
0.96 [0.78, 1.18] |
6.1.1 Mefenamic acid 250 mg versus PAC 500 mg |
1 |
108 |
Risk Ratio (M‐H, Fixed, 95% CI) |
0.97 [0.69, 1.35] |
6.1.2 Mefenamic acid 250 mg versus Melissa Officinalis 395 mg |
1 |
110 |
Risk Ratio (M‐H, Fixed, 95% CI) |
0.73 [0.37, 1.45] |
6.1.3 Mefenamic acid 250 mg versus fennel 300 mg |
1 |
86 |
Risk Ratio (M‐H, Fixed, 95% CI) |
1.00 [0.71, 1.41] |
6.1.4 Ibuprofen 400 mg versus fennel essence 20% |
1 |
90 |
Risk Ratio (M‐H, Fixed, 95% CI) |
1.05 [0.66, 1.69] |
6.2 Need for additional pain relief |
1 |
|
Risk Ratio (M‐H, Fixed, 95% CI) |
Totals not selected |
6.2.1 Ibuprofen 400 mg versus fennel essence 20% |
1 |
|
Risk Ratio (M‐H, Fixed, 95% CI) |
Totals not selected |
6.3 Pain however measured by the authors |
1 |
|
Mean Difference (IV, Fixed, 95% CI) |
Totals not selected |
6.3.1 VAS 0‐10 |
1 |
|
Mean Difference (IV, Fixed, 95% CI) |
Totals not selected |
6.4 Maternal adverse events |
1 |
|
Risk Ratio (M‐H, Fixed, 95% CI) |
Totals not selected |
6.4.1 Mefenamic acid 250 mg versus PAC 500 mg |
1 |
|
Risk Ratio (M‐H, Fixed, 95% CI) |
Totals not selected |